Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross‐Sectional Descriptive Study as Part of the PharmLines Initiative

BACKGROUND: Drug-drug interaction (DDI) is one of the main contributors to adverse drug reactions and therefore, it is important to study its frequency in the population. We aimed to investigate frequency and concordance on CYP2D6, CYP2C19, and CYP2C9 (CYP2D6/2C19/2C9)-mediated potential DDIs at the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahar, Muh. Akbar, Bos, Jens H. J., Borgsteede, Sander D., Dotinga, Aafje, Alingh, Rolinde A., Wilffert, Bob, Hak, Eelko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225338/
https://www.ncbi.nlm.nih.gov/pubmed/32457621
http://dx.doi.org/10.3389/fphar.2020.00624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225338/
https://www.ncbi.nlm.nih.gov/pubmed/32457621
http://dx.doi.org/10.3389/fphar.2020.00624

Ejemplares similares